Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	151.53	256.76	-102.08
Graham Fair Price	302.32	17467.80	4341.78
PEG	-99.32	< 0.005	0.24
Price/Book	-5.43	0.59	0.63
Price/Cash Flow	222.59	936.25	290.23
Prices/Earnings	-93.47	2.71	-41.48
Price/Sales	-41.23	68.18	116.01
Price/FCF	222.59	936.25	290.23
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-31.49	0.25	-0.36
Operating Margin	41.22	-0.89	-1.52
ROA	1350.43	0.05	< 0.005
ROE	< 0.005	0.05	1347.74
ROIC	< 0.005	< 0.005	-84.50
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.51	-0.11	-361.23
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.28	< 0.005	-99.94
EPS QOQ	-1.70	16.32	861.67
FCF QOQ	1.88	-0.69	-63.20
Revenue QOQ	-0.39	0.70	79.27
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	71.94	80.79	12.31
Days Sales Outstanding (DSO)	480.52	221.47	-53.91
Inventory Turnover	1.25	1.11	-10.96
Debt/Capitalization	< 0.005	< 0.005	-53.94
Quick Ratio	6.22	4.62	-25.76
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	14882.06	15735.77	5.74
Cash	885.94	610.48	-31.09
Capex	0.00	-1.76	-100.00
Free Cash Flow	32.18	9.98	-69.00
Revenue	80.51	137.00	70.16
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	5.48	5.25	-4.07
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.39	-17.05	166.92
Naive Interpretation	Member

06 - Financial Health · Bad

Rating